Deep Dive: Market Access

Market Access

12 questions with: Daniel Kohlstaedt

Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.

Market Access

Around the world in pharma events

Stay up to date with key industry meetings and conferences in 2023

Market Access

How to solve a problem like DTx in Europe?

The promise of digital therapeutics (DTx) has been widely discussed and debated since the term first began to emerge back in the early 2010s.

Market Access

CSL opens a new R&D facility in Waltham, Massachusetts

On March 27th, global biopharma company CSL opened a new R&D facility in Waltham, Massachusetts.

Market Access

What the HRT is happening with menopause care in the UK?

Menopause is a natural process that occurs as women age and marks the end of their reproductive years.

Market Access

eyeforpharma 2020: Redefining value for COVID-19 and beyond

The coronavirus pandemic was front and centre of everyone’s minds at this year’s spring eyeforpharma conferences – not least because the usual locations of Barcelona and Philadelphia had been swapp

12 questions with: Daniel Kohlstaedt

Around the world in pharma events

How to solve a problem like DTx in Europe?

CSL opens a new R&D facility in Waltham, Massachusetts

What the HRT is happening with menopause care in the UK?

eyeforpharma 2020: Redefining value for COVID-19 and beyond

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

Deep Dive: Market Access

Editor's Picks